Dr. Imran Ashraf, MD
Gastroenterology (Gastroenterology Physician)
1241 W Stadium Blvd
Jefferson City, MO 65109
Who else practices at this address →
Cole County is a federal primary care and dental shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 22
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 560
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
MO license 2010017204 -
Internal Medicine Physician
MO license 2010017204
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Missouri Health Care Columbia, MO
- Ssm Health St. Mary's Hospital - Jefferson City Jefferson City, MO
Medical groups
- The Curators of the University of Missouri (1,131 clinicians)
- Jefferson City Medical Group PC (119 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 560
- Services billed
- 1,998
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 289 | 114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 253 | 251 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 164 | 156 |
| Established patient office or other outpatient visit, 20-29 minutes | 118 | 94 |
| Insertion of needle into vein for collection of blood sample | 90 | 54 |
| Special stained specimen slides to examine tissue including interpretation and report | 88 | 42 |
| Biopsy of large bowel using a flexible endoscope | 75 | 74 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 66 | 26 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 59 | 54 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 51 | 49 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Jefferson City, MO | 233 |
| Omeprazole Other prescribers in Jefferson City, MO | 222 |
| Famotidine Other prescribers in Jefferson City, MO | 87 |
| Dicyclomine Hcl Other prescribers in Jefferson City, MO | 82 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Jefferson City, MO | 81 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Jefferson City, MO | 70 |
| Mesalamine Other prescribers in Jefferson City, MO | 39 |
| Balsalazide Disodium | 39 |
| Esomeprazole Magnesium Other prescribers in Jefferson City, MO | 37 |
| Mesalamine Er (mesalamine) Other prescribers in Jefferson City, MO | 37 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 8 payments worth $203 in total to this clinician.
| Janssen Biotech, Inc. | $84.99 |
|---|---|
| Aimmune Therapeutics, Inc. | $35.44 |
| Pfizer Inc. | $21.05 |
| Amgen Inc. | $19.47 |
| Ipsen Biopharmaceuticals, Inc | $14.58 |
| AbbVie Inc. | $14.35 |
| Phathom Pharmaceuticals, Inc. | $12.83 |
| Food and Beverage | $118 |
|---|---|
| Education | $84.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Jun 19, 2025 | Education TREMFYA · Immunology · in-kind | $84.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $41,807 in research payments for these studies, mostly to the institutions running them.
- Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132)
Bausch Health US, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.